Psoriasis Clinical Trial

Improving Disease Severity

Summary

Phototherapy, including ultraviolet B (UVB) and ultraviolet A (UVA) light, has been used to treat a number of dermatologic conditions. Psoriasis is one of the most common conditions treated with phototherapy, in which phototherapy is often indicated for extensive disease with contraindications for other systemic treatments. The mechanism of action of phototherapy for the treatment of psoriasis is not completely understood; however, it is known that UVB light induces apoptosis of pathogenic T cells and keratinocytes, which may reduce the overactive immune response and epidermal hyperproliferation. Phototherapy has shown some efficacy for other diseases, such as alopecia areata (AA) and polymorphous light eruption (PMLE). However, phototherapy is not always an accessible treatment option for patients due to cost or lack of time.

View Full Description

Full Description

Recent advancements in nanotechnology have led to the development of medical devices (lasers and LED devices) with unique phototherapy properties that emit radiation in the infrared wavelengths, allowing patients to benefit from the effects of phototherapy treatment in a more convenient way. Preclinical studies demonstrated the positive effects of infrared radiation exposure on the skin including, increased collagen synthesis and expression of transforming growth factor-beta1 (TGF-beta1). Other studies suggested possible antimicrobial effects from infrared radiation, with decreased colonization of Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae on the skin after exposure. Compared to other fabric technology, such as Far-Infrared (FIR) fabric technology that reflects body heat, fabric made from Lumiton yarn converts external light in the UV and visible spectrum and emits light in the red and near-infrared spectrum for the body. Lumiton yarn absorbs energy from 350 nm to 600 nm (the light spectrum from UV to visible red light) and emit energy from 600 to 1000 nm (red, near-infrared spectrum). The Lumiton yarn contains red/NIR light-emitting dyes. The effectiveness of the technology is proportional to the intensity of the light, with its peak effectiveness under sunlight.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult participants ≥18 years of age
Participants who live in the US,
Participants who are diagnosed with mild-to-severe AA, PMLE, or psoriasis
Participants have sufficient command of the English language

Exclusion Criteria:

Participants less than the age of 18
Participants who do not live in the US
Participants who are not diagnosed with mild to severe AA, PMLE, or psoriasis
Participants without a sufficient command of the English language
Participants with concurrent medical conditions that are at risk of confounding the study outcomes
Participants currently using concomitant phototherapy

Study is for people with:

Psoriasis

Estimated Enrollment:

15

Study ID:

NCT05391178

Recruitment Status:

Recruiting

Sponsor:

Wake Forest University Health Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Wake Forest University Health Sciences, Dermatology
Winston-Salem North Carolina, 27157, United States More Info
Irma M Richardson, MHA
Contact
336-716-2903
[email protected]
Joseph Jorizzo, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Estimated Enrollment:

15

Study ID:

NCT05391178

Recruitment Status:

Recruiting

Sponsor:


Wake Forest University Health Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.